DAIC AHA Trial image
News | Atrial Fibrillation
Positive Results from ReVeRA Phase 2 Study of Etripamil Nasal Spray in AFib-RVR Presented by Milestone Pharmaceuticals during AHA 2023

November 24, 2023 — During the American Heart Association Scientific Sessions 2023, held recently in Philadephia, PA ...

Home November 22, 2023
Home
A groundbreaking advancement in the treatment of patients with uncontrolled hypertension (HTN) has been achieved with the recent U.S. Food & Drug Administration (FDA) approvals of two renal denervation (RDN) systems
News | Artificial Intelligence
Renal HeartSciences Announces Closing of License Agreements with the Icahn School of Medicine at Mount Sinai to Develop and Commercialize AI Cardiovascular Algorithms

November 22, 2023 — Heart Test Laboratories, Inc. d/b/a HeartSciences, an artificial intelligence (AI)-powered medical ...

Home November 22, 2023
Home
Medinbox Link and Medinbox Air deliver cutting-edge technologies to enhance digital education and remote proctoring and support for cath labs and interventional rooms globally
News | Artificial Intelligence
Medinbox Advances Company Mission to Improve Access to Medical Education and Remote Support Around the World with Debut of New Product Suites for Interventional Ecosystem at TCT

November 22, 2023 — Medinbox, a leading global provider of video integrated collaboration systems for interventional ...

Home November 22, 2023
Home
The first clinical trial to challenge the routine implantation of a defibrillator in myocardial infarction survivors with heart failure has enrolled its first patient.
News | Cardiovascular Clinical Studies
Trial to Prevent Sudden Death After a Heart Attack Enrolls First Patient

November 22, 2023 — The first clinical trial to challenge the routine implantation of a defibrillator in myocardial ...

Home November 22, 2023
Home
Acoramidis
News | Pharmaceuticals
BridgeBio Pharma Presents Additional Clinical Outcomes Data from the Phase 3 ATTRibute-CM Study of Acoramidis in Patients with Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)

November 21, 2023 — BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company focused on genetic diseases and ...

Home November 21, 2023
Home
New partnership paves the way for early diagnosis and intervention to improve cardiovascular outcomes and quality of life for patients
News | ECG
AccurKardia Delivers its ECG Interpretation Software Within the Lucem Health Reveal Family of Clinical AI Solutions

November 21, 2023 — AccurKardia, an ECG-led diagnostics software company, announced a multi-year agreement with Lucem ...

Home November 21, 2023
Home
AI-powered NeuroShield automatically quantifies brain volumes using MRI data – the first of its kind with the capability to provide ethnicity-specific reference ranges
News | Artificial Intelligence
Heuron Showcasing Neuro AI Solutions and Presenting Abstract on AI Solutions for Stroke at RSNA23

November 21, 2023 — Heuron, a medical AI (artificial intelligence) imaging software solution company, under the ...

Home November 21, 2023
Home
A cardiac follow-up is recommended for all children who have been treated for MIS-C
News | Pediatric Cardiology
Investigators at Children’s Hospital Los Angeles Find Heart Complications in Many Children Treated for MIS-C

November 20, 2023 — In the U.S., nearly 10,000 children and adolescents have developed a condition called multisystem ...

Home November 20, 2023
Home
New data from the ARIES trial show for the first time that an aspirin-free regimen can improve outcomes for people living with the heart pump by reducing hospitalizations without increasing the risk of blood clots
News | Heart Valve Technology
Late-breaking Data Show an Aspirin-free Medication Regimen Benefits People with Abbott’s HeartMate 3 Heart Pump

November 20, 2023 — Abbott announced new late-breaking data that show advanced heart failure patients living with its ...

Home November 20, 2023
Home
Team Bath Heart’s artificial heart wins top prize at international engineering & design contest
News | Artificial Heart
Heart of Gold: Bath Student Team Wins World Heart Hackathon Competition

November 20, 2023 — Student engineers from the University of Bath are on top of the world after winning an international ...

Home November 20, 2023
Home
Approval is the culmination of ten years of clinical research and development of the Medtronic renal denervation technology
News | Renal Denervation
Medtronic Announces FDA Approval of Minimally Invasive Device to Treat Hypertension

November 20, 2023 — Medtronic plc, a global leader in healthcare technology, announced that the United States Food and ...

Home November 20, 2023
Home
A groundbreaking advancement in the treatment of patients with uncontrolled hypertension (HTN) has been achieved with the recent U.S. Food & Drug Administration (FDA) approvals of two renal denervation (RDN) systems
News | FDA
Renal Denervation Systems Receive FDA Approval, Revolutionizing Treatment for Uncontrolled Hypertension

November 20, 2023 — A groundbreaking advancement in the treatment of patients with uncontrolled hypertension (HTN) has ...

Home November 20, 2023
Home
Recent recommendations for remote monitoring of implantable devices may require healthcare organizations to rethink how they staff their operations
Feature | Remote Monitoring | By Arnaud Rosier, MD, PhD
Expert Consensus on Remote Monitoring: Key Staffing Takeaways

This past spring, electrophysiology experts issued new recommendations for remote monitoring of cardiovascular ...

Home November 20, 2023
Home
Investigators in the Smidt Heart Institute found that electrocardiogram changes picked up over time could indicate increased risk
News | Sudden Cardiac Arrest
Cedars-Sinai Investigators Move Closer to Predicting Sudden Cardiac Arrest

November 17, 2023 — Sudden cardiac arrest remains a deadly and complex condition, but investigators in the Smidt Heart ...

Home November 17, 2023
Home
BioCardia announces that the Food and Drug Administration (FDA) has approved its proposed CardiAMP Heart Failure II study protocol
News | FDA
BioCardia Announces FDA Approval of CardiAMP Heart Failure II Protocol for Autologous Cell Therapy for Ischemic Heart Failure

November 17, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home November 17, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now